Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

GlaxoSmithKline PLC ADR (GSK)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow GlaxoSmithKline ADR's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
39.01 +0.29    +0.75%
15/10 - Closed. Currency in USD ( Disclaimer )
After Hours
38.95
-0.06
-0.15%
0:35:46 - Real-time Data
  • Volume: 3,264,677
  • Bid/Ask: 38.80 / 39.03
  • Day's Range: 38.71 - 39.03
Type:  Equity
Market:  United States
ISIN:  US37733W1053 
CUSIP:  37733W105
GlaxoSmithKline ADR 39.01 +0.29 +0.75%

GSK Financial Summary

 
See below for an overview of the GlaxoSmithKline financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

For the six months ended 30 June 2021,GlaxoSmithKline plc (ADR) revenues decreased 7% to £15.51B.Net income decreased 36% to £2.47B. Revenues reflectConsumer Healthcare segment decrease of 56% to £2.29B,Pharmaceuticals segment decrease of 23% to £6.53B, Vaccinessegment decrease of 47% to £1.57B, US segment decrease of48% to £3.52B, Rest of world segment decrease of 53% to£2.71B, Europe segment decrease of 54% to £1.87B.

AnnualQuarterly
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

GSK Income Statement

Gross margin TTM 67.75%
Operating margin TTM 19.11%
Net Profit margin TTM 15.4%
Return on Investment TTM 9.78%
 Total Revenue  Net Income
Period Ending: Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Total Revenue 8092 7418 8739 8646
Gross Profit 5573 5007 5777 5928
Operating Income 1675 1693 1061 1858
Net Income 1395 1073 677 1244

GSK Balance Sheet

Quick Ratio MRQ 0.53
Current Ratio MRQ 0.82
LT Debt to Equity MRQ 132.94%
Total Debt to Equity MRQ 165.72%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Total Assets 77011 78079 80431 80927
Total Liabilities 61634 63214 65844 66641
Total Equity 15377 14865 14587 14286

GSK Cash Flow Statement

Cash Flow/Share TTM 3.34
Revenue/Share TTM 17.92
Operating Cash Flow  7.59%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Period Length: 6 Months 3 Months 12 Months 9 Months
Cash From Operating Activities 1623 331 8441 4586
Cash From Investing Activities -233 -48 2161 2213
Cash From Financing Activities -3421 -1376 -10132 -7957
Net Change in Cash -2065 -1128 431 -1175
* In Millions of GBP (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GSK Comments

Write your thoughts about GlaxoSmithKline PLC ADR
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
GSK movie forward. Thanks you
Reply
2 0
Report
Faruk Mia
Faruk Mia Apr 27, 2021 7:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
হাই
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email